Systemic agonistic anti-CD40 treatment of tumor bearing mice modulates hepatic myeloid suppressive cells and causes immune-mediated liver damage

Por Medina-Echeverz, José, Ma, Chi, Duffy, Austin, Eggert, Tobias, Hawk, Nga, Kleiner, David E., Korangy, Firouzeh, Greten, Tim F.
Publicado no Cancer Immunol Res (2015)

CD200-expressing human basal cell carcinoma cells initiate tumor growth

Por Colmont, Chantal S., BenKetah, Antisar, Reed, Simon H., Hawk, Nga V., Telford, William G., Ohyama, Manabu, Udey, Mark C., Yee, Carole L., Vogel, Jonathan C., Patel, Girish K.
Publicado em 2013

CD40 dependent exacerbation of immune mediated hepatitis by hepatic CD11b(+) Gr-1(+) myeloid derived suppressor cells in tumor bearing mice

Por Kapanadze, Tamar, Medina-Echeverz, José, Gamrekelashvili, Jaba, Weiss, Jonathan M., Wiltrout, Robert H., Kapoor, Veena, Hawk, Nga, Terabe, Masaki, Berzofsky, Jay A., Manns, Michael P., Wang, Ena, Marincola, Francesco M., Korangy, Firouzeh, Greten, Tim F.
Publicado no Eur J Immunol (2015)

miR-155 augments CD8(+) T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γ(c) cytokines

Por Ji, Yun, Wrzesinski, Claudia, Yu, Zhiya, Hu, Jinhui, Gautam, Sanjivan, Hawk, Nga V., Telford, William G., Palmer, Douglas C., Franco, Zulmarie, Sukumar, Madhusudhanan, Roychoudhuri, Rahul, Clever, David, Klebanoff, Christopher A., Surh, Charles D., Waldmann, Thomas A., Restifo, Nicholas P., Gattinoni, Luca
Publicado no Proc Natl Acad Sci U S A (2015)